Deleuran, M., D. Marcoux, M. S. De Bruin-Weller, A. D. Irvine, E. Baselga, K. Ahn, A. P. Castro, A. Bansal, J. Chao, G. Bégo-Le-Bagousse, and A. B. Rossi. “Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents With Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use”. Acta Dermato-Venereologica, vol. 101, no. 7, July 2021, p. adv00504, doi:10.2340/00015555-3848.